Intercept Pharmaceuticals

📍 Morristown, United States🗓 Founded 2002👥 373 employees💰 Last funded Nov 2015
Pharmaceutical Manufacturing🌐 interceptpharma.com
Website LinkedIn
We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs. Our corporate headquarters is located in New Jersey. For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on X at: @InterceptPharma.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2002
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Intercept Pharmaceuticals?
Intercept Pharmaceuticals has 2 investors on record on gritt.io and 1 late-stage investors.
When did Intercept Pharmaceuticals last raise funding?
The most recent investment in Intercept Pharmaceuticals recorded on gritt.io was in November 2015.
When was Intercept Pharmaceuticals founded?
Intercept Pharmaceuticals was founded in 2002.
What industry is Intercept Pharmaceuticals in?
Intercept Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Intercept Pharmaceuticals based?
Intercept Pharmaceuticals is headquartered in Morristown, United States.